Form 4: DaVita Inc. Director Charles Berg Acquires Shares in Recent Transaction

Director Charles Berg acquired 312 shares of DaVita Inc. common stock on November 15, 2024, increasing his direct holdings.

Summary

• Charles Berg, a director at DaVita Inc., acquired 312 shares of common stock on November 15, 2024.
• The shares were acquired at a price of $0, indicating they were likely awarded as part of a compensation package.
• Following the transaction, Mr. Berg directly owns 19,285 shares of DaVita Inc. common stock.
• Mr. Berg also indirectly owns 7,047 shares through the Charles G. Berg 2016 Family Trust U/A DTD 02/05/2016.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as the acquisition of shares by a director can be seen as a sign of confidence, but it's a routine transaction.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It provides transparency into the ownership changes of company directors.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and DaVita's filing is consistent with these requirements.
• Similar filings are made by directors and officers of companies like Fresenius Medical Care and Baxter International, which are also in the healthcare sector.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it indicates director confidence in the company.

Key Dates

Keywords

DaVita Inc., Charles Berg, stock acquisition, director, insider trading, Form 4, share ownership